NASDAQ:ICLR
ICON plc Stock News
$315.39
+0.350 (+0.111%)
At Close: May 10, 2024
PRA HEALTH SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRAH and Encourages Investors to Contact the Firm
12:09pm, Wednesday, 24'th Feb 2021
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PRA Health
Icon PLC (ICLR) Surpasses Q4 Earnings and Revenue Estimates
08:21am, Wednesday, 24'th Feb 2021
Icon PLC (ICLR) delivered earnings and revenue surprises of 3.83% and 1.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
ICON Reports Fourth Quarter and Full Year 2020 Results
06:01am, Wednesday, 24'th Feb 2021
DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2020 Results
ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research
06:00am, Wednesday, 24'th Feb 2021
DUBLIN--(BUSINESS WIRE)--ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research
ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support
04:30am, Monday, 08'th Feb 2021
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the r
ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference
04:15pm, Thursday, 07'th Jan 2021
DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference
ICON Supports Pfizer and BioNTech on the Investigational COVID-19 Vaccine Trial
04:15am, Monday, 04'th Jan 2021
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device ind
ICON Plc -- Moody's affirms Baa3 issuer rating of ICON Plc, stable outlook
05:30pm, Thursday, 30'th Jul 2020
Moody's Investors Service, ("Moody's") has today affirmed the Baa3 long term issuer rating of ICON Plc ("ICON" or "the company"). ICON is strongly positioned in the Baa3 rating. Additionally, Moody'
Icon PLC: A CRO Momentum Stock Worth Backing Long Term
11:45am, Wednesday, 29'th Jul 2020
Icon is a contract research organisation specialising in conducting clinical trials for biotechs and big pharma.
ICON Public Limited Company (ICLR): Were Hedge Funds Right About This Stock?
12:29am, Tuesday, 28'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Safely
03:16pm, Monday, 27'th Jul 2020
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
ICON Public Limited Company 2020 Q2 - Results - Earnings Call Presentation
06:34am, Monday, 27'th Jul 2020
The following slide deck was published by ICON Public Limited Company in conjunction with their 2020 Q2 earnings call.
Icon PLC (ICLR) Q2 2020 Earnings Call Transcript
01:01am, Friday, 24'th Jul 2020
ICLR earnings call for the period ending June 30, 2020.
ICON's (ICLR) CEO Steven Cutler on Q2 2020 Results - Earnings Call Transcript
03:38pm, Thursday, 23'rd Jul 2020
ICON Public Limited Company (NASDAQ:ICLR) Q2 2020 Earnings Conference Call July 23, 2020 9:00 AM ET Company Participants Steve Cutler – Chief Executive Officer Brendan Brennan – Chief Financial Of
Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates
11:35pm, Wednesday, 22'nd Jul 2020
Icon PLC (ICLR) delivered earnings and revenue surprises of 9.09% and 4.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
